↓ Skip to Main Content
  • Home
  • Site Map
Vichem
  • About us
    • Vision & Mission
    • CEO
    • Strategic alliances
    • Partners
    • Top publications
    • Patent applications
  • Services
    • Fluorescent labeling of small molecules
    • Synthetic chemistry services for target identification
    • Custom synthesis
    • Contract research
    • Hit finding, assay development & screening
    • Hit to lead optimization, patentable lead generation
    • Process development & optimization
    • Liquid handling & sample management
    • Analytical Services
  • Compound libraries
    • Building blocks
    • Artemisinin derivatives
    • Nested Chemical Library™ (NCL)
    • Allosteric Library (AL)
    • Tool Compound Libary (TCL)
  • R&D projects
    • Myeloma and solid tumors
    • Development of selective FLT3 inhibitors
    • HIV
    • Other Projects
  • NRDI grants
    • TÉT_13_DST
    • KMR_12
  • EC grants
  • Pipeline
  • Contact us
Menu
Home › Partners

Partners

Addex Therapeutics
www.addextherapeutics.com

Bayer
www.bayer.com

BioBlocks Inc.
www.bioblocks.com

Galapagos NV
www.glpg.com

Johnson & Johnson
www.jnj.com

Institut Pasteur, Laboratory of Integrated Mycobacterial Pathogenomics
research.pasteur.fr/en/team/integrated-mycobacterial-pathogenomics

Institut Pasteur, Laboratory of Structural Microbiology
research.pasteur.fr/en/team/structural-microbiology

King’s College London
www.kcl.ac.uk

Laboratory of Protein Phosphorylation and Proteomics, KU Leuven
www.kuleuven.be

Medical University of Innsbruck
www.i-med.ac.at

OcellO
ocello.nl

Pfizer
www.pfizer.com

ProQinase
www.proqinase.com

Qurient Therapeutics
www.qurient.com

Schrödinger Inc.
www.schrodinger.com

Bacterial Cell Biology, Swammerdam Institute for Life Sciences, University of Amsterdam
sils.uva.nl

Department of Biological Regulation, The Weizmann Institute of Science
www.weizmann.ac.il

Sugen

Axxima Pharmaceuticals AG

GPC Biotech

    © 2023 Vichem
    ↑
    The Kinase Inhibitor Company